SonoDynamic Therapy (SDT)

SDT, then, employs both light and sound frequencies to damage and destroy cancer cells in a non-invasive and non-toxic procedure.

In plain language, the sensitising agent primes the tumour cells to specific frequencies but has no effect on regular, healthy cells. Administration of SDT through localised and whole body routes then causes a reaction within the sensitised tumour cells, which results in the formation of reactive oxygen species, destroying the tumour mass.

As the therapy has minimal side effects and does not damage surrounding tissues, SDT is increasingly the preferred cancer treatment for those who have not responded to previous treatment – and especially in the case of metastatic cancers.

A wide variety of cancers have been successfully treated using SDT in conjunction with elements of both Western and Chinese medicine, including advanced breast, prostate, stomach, lung, brain, colorectal, maxillary sinus, skin and epithelial soft tissue cancers.

Key Advantages of SDT Include:

The downsides are few, namely the limited availability of SDT in the Western world and the fact that, in some Western countries, the treatment is not covered by state or private health insurance.

SDT Based Treatment

SDT and all standard treatments for metastatic cancer are rarely curative. Treatment needs to continue indefinitely. This is almost always impractical with standard treatments. Chemotherapy and radiation therapy are dangerous and too often lose efficacy for longer term use.

SoSDT 4 LIFE has added an effective, affordable follow up program which can be used indefinitely to attack any remaining cancer, and any newly developing cancers.

SDT is the basic treatment to immediately and effectively attack all cancer including metastases. The follow up program maintains that attack on remaining cancer and reduces the risk (or defers the occurrence) of recurring cancer.

We recommend continuing this follow up program until there is no evidence of remaining cancer, and then to take (cheaper) maintenance doses indefinitely.

SDT Treatment Outcomes

When evaluating patient outcomes, it is important to remember that almost all SDT patients have tried standard therapies, with minimal, if any, success. By the time they turn to SDT treatment, the disease has usually progressed, their bodies have been damaged by previous treatments, many are in poor general health and have large cancer loads. They typically have no other reasonable treatment options.

Despite these handicaps, SDT does amazingly well.

Eminent Melbourne-based Australian scientist Dr. Doug Mitchell – who currently serves as a scientific consultant to the team at SoSDT 4 LIFE and has been actively involved in researching the outcomes of SDT treatment for nearly 10 years – believes some 80% of patients he has worked with have significantly benefited from the treatment, some spectacularly so.

In his words, he says he has seen patients arrive for treatment looking in dreadful health only to emerge a few weeks later looking terrific.

“I recall a patient who arrived at SoSDT 4 LIFE in a wheelchair and was coughing constantly. A few months later, we caught up for lunch, there was no coughing and she had just been for a 150-metre swim in the pool,” he said.

“Every doctor I have spoken to who is familiar with SDT believes it is the best treatment for metastatic cancer. It is also new technology and new technology improves with time, so we can confidently expect even better outcomes as the technology is developed.”

Note also that the patients who fail to benefit from SDT fail because they have incurred too much damage from the cancer and/or from previous treatment. They have reached a “point of no return” where even if all cancer magically disappeared, they wouldn’t make it because of their pre-existing damage. They are not treatment failures.